CELULARITY INC.

Analyst Reco. Celularity Inc.

Equities

CELU

US1511902041

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
3.02 ^USD	-1.63%		-0.33%	+22.07%

Mar. 26	Celularity Receives Healthcare Common Procedure Coding System Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance 3L	CI
Mar. 20	Celularity Seeks FDA Orphan Drug Status for PDA-002 in Facioscapulohumeral Muscular Dystrophy	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Lowers Price Target on Celularity to $2.50 From $15, Maintains Buy Rating	23-01-30	MT
Morgan Stanley Downgrades Celularity to Underweight From Equalweight, Adjusts Price Target to $1 From $5	23-01-30	MT
Oppenheimer Downgrades Celularity to Perform From Outperform, Removes $6 Price Target	22-12-22	MT
Oppenheimer Adjusts Celularity Price Target to $6 From $8, Maintains Outperform Rating	22-11-14	MT
Morgan Stanley Trims Celularity's Price Target to $5 From $8, Keeps Equalweight Rating	22-09-12	MT
Alliance Global Partners Initiates Coverage on Celularity With Buy Rating, $15 Price Target	22-08-25	MT
Truist Securities Trims Price Target on Celularity to $6 From $10, Reiterates Hold Rating	22-08-23	MT
Oppenheimer Adjusts Celularity Price Target to $8 From $10, Maintains Outperform Rating	22-08-11	MT
HC Wainwright Starts Celularity at Buy With $15 Price Target	22-06-22	MT
Truist Securities Downgrades Celularity to Hold From Buy	22-04-06	MT
Oppenheimer Initiates Celularity With Outperform Rating, $9 Price Target	22-01-28	MT
Celularity Stock Drops as Morgan Stanley Initiates Ratings Coverage at Equal-Weight	21-11-24	MT
Morgan Stanley Starts Celularity at Equal-Weight With $9 Price Target	21-11-24	MT
CELULARITY : Truist Securities Initiates Celularity Class at Buy Rating With $12 Price Target	21-10-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer